JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
Cardinal Health
CAH
$53.6B
| $46.5M | 0.01% |
998,406
-36,244
| -4% | -$1.67M |
2013 Q2
24 quarters
|
|
1002
PUT
Berkshire Hathaway Class B
BRK.B
$1.08T
| $46.5M | 0.01% |
219,400
+119,400
| +119% | +$24.7M |
2015 Q3
15 quarters
|
|
1003
CALL
Johnson & Johnson
JNJ
$611B
| $46.4M | 0.01% |
329,900
+112,500
| +52% | +$15.6M |
2014 Q3
19 quarters
|
|
|
SJR
1004
DELISTED
Shaw Communications Inc.
SJR
| $46.3M | 0.01% |
2,270,906
+959,463
| +73% | +$19.5M |
2013 Q2
24 quarters
|
|
1005
MGIC Investment
MTG
$5.54B
| $46M | 0.01% |
3,503,987
+957,460
| +38% | +$13.3M |
2013 Q2
24 quarters
|
|
1006
OGE Energy
OGE
$9.29B
| $46M | 0.01% |
1,092,244
-50,846
| -4% | -$2.15M |
2013 Q2
24 quarters
|
|
1007
PUT
ExxonMobil
XOM
$672B
| $45.9M | 0.01% |
605,900
+175,600
| +41% | +$13.6M |
2014 Q2
20 quarters
|
|
1008
CALL
AbbVie
ABBV
$463B
| $45.9M | 0.01% |
656,000
+489,500
| +294% | +$38.5M |
2018 Q2
4 quarters
|
|
1009
CALL
Comcast
CMCSA
$76.3B
| $45.8M | 0.01% |
1,090,000
+934,400
| +601% | +$39.4M |
2014 Q3
19 quarters
|
|
1010
Acco Brands
ACCO
$396M
| $45.7M | 0.01% |
5,941,729
+104,622
| +2% | +$857K |
2013 Q2
24 quarters
|
|
1011
Nucor
NUE
$56.1B
| $45.6M | 0.01% |
835,896
-17,994
| -2% | -$989K |
2013 Q2
24 quarters
|
|
1012
Omnicom Group
OMC
$20.5B
| $45.6M | 0.01% |
562,574
+11,233
| +2% | +$886K |
2013 Q2
24 quarters
|
|
1013
CALL
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$114M
| $45.6M | 0.01% |
+1,626,500
| New | +$36.6M |
2019 Q2
0 quarters
|
|
1014
State Street SPDR S&P Health Care Equipment ETF
XHE
$182M
| $45.5M | 0.01% |
563,091
+794
| +0.1% | +$62K |
2017 Q2
8 quarters
|
|
|
JPMF
1015
DELISTED
JPMorgan Managed Futures Strategy ETF
JPMF
| $45.4M | 0.01% |
1,869,104
-87,594
| -4% | -$2.1M |
2017 Q4
6 quarters
|
|
1016
State Street SPDR S&P Retail ETF
XRT
$386M
| $45.1M | 0.01% |
1,072,375
-375,620
| -26% | -$16.3M |
2013 Q2
24 quarters
|
|
1017
Louisiana-Pacific
LPX
$4.6B
| $44.9M | 0.01% |
1,730,715
+155,641
| +10% | +$3.81M |
2015 Q4
14 quarters
|
|
|
KL
1018
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $44.8M | 0.01% |
1,053,657
+1,028,310
| +4,057% | +$35.7M |
2019 Q1
1 quarter
|
|
1019
iShares MSCI Hong Kong ETF
EWH
$1.15B
| $44.7M | 0.01% |
1,720,277
+1,671,734
| +3,444% | +$43.2M |
2013 Q2
24 quarters
|
|
1020
Petrobras
PBR
$156B
| $44.7M | 0.01% |
2,876,747
-803,173
| -22% | -$12.2M |
2013 Q2
24 quarters
|
|
1021
Moderna
MRNA
$77.3B
| $44.6M | 0.01% |
3,112,030
+1,675,790
| +117% | +$36M |
2018 Q4
2 quarters
|
|
1022
Littelfuse
LFUS
$11.6B
| $44.5M | 0.01% |
251,849
-25,760
| -9% | -$4.67M |
2013 Q2
24 quarters
|
|
|
GTHX
1023
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $44.4M | 0.01% |
1,429,138
+310,614
| +28% | +$6.54M |
2017 Q4
6 quarters
|
|
1024
Freeport-McMoran
FCX
$104B
| $44.4M | 0.01% |
3,842,548
-457,071
| -11% | -$5.32M |
2013 Q2
24 quarters
|
|
1025
Winnebago Industries
WGO
$703M
| $44.3M | 0.01% |
1,159,133
+205,835
| +22% | +$7.24M |
2016 Q1
13 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.